TY - JOUR
T1 - Repurposing Disulfiram as an Antimicrobial Agent in Topical Infections
AU - Lajarin-Reinares, Maria
AU - Pena-Rodríguez, Eloy
AU - Cañellas-Santos, Mariona
AU - Rosell-Vives, Elisabet
AU - Cortés, Pilar
AU - Casas, Montserrat Llagostera
AU - Calvo, Maria Àngels
AU - Fernandez-Campos, Francisco
N1 - Funding Information:
This research was funded by the Generalitat of Catalonia, Industrial Doctorate Program, grant number 2020 DI 97.
Publisher Copyright:
© 2022 by the authors.
PY - 2022/12/4
Y1 - 2022/12/4
N2 - Antimicrobial drugs applied topically offer several advantages. However, the widespread use of antibiotics has led to increasing antimicrobial resistance. One interesting approach in the drug discovery process is drug repurposing. Disulfiram, which was originally approved as an anti-alcoholism drug, offers an attractive alternative to treat topical multidrug resistance bacteria in skin human infections. This study aimed to evaluate the biopharmaceutical characteristics of the drug and the effects arising from its topical application in detail. Microdilution susceptibility testing showed antibacterial activity against Gram-positive bacteria Staphylococcus aureus and Streptococcus pyogenes. Dermal absorption revealed no permeation in pig skin. The quantification of the drug retained in pig skin demonstrated concentrations in the stratum corneum and epidermis, enough to treat skin infections. Moreover, in vitro cytotoxicity and micro-array analyses were performed to better understand the mechanism of action and revealed the importance of the drug as a metal ion chelator. Together, our findings suggest that disulfiram has the potential to be repurposed as an effective antibiotic to treat superficial human skin infections.
AB - Antimicrobial drugs applied topically offer several advantages. However, the widespread use of antibiotics has led to increasing antimicrobial resistance. One interesting approach in the drug discovery process is drug repurposing. Disulfiram, which was originally approved as an anti-alcoholism drug, offers an attractive alternative to treat topical multidrug resistance bacteria in skin human infections. This study aimed to evaluate the biopharmaceutical characteristics of the drug and the effects arising from its topical application in detail. Microdilution susceptibility testing showed antibacterial activity against Gram-positive bacteria Staphylococcus aureus and Streptococcus pyogenes. Dermal absorption revealed no permeation in pig skin. The quantification of the drug retained in pig skin demonstrated concentrations in the stratum corneum and epidermis, enough to treat skin infections. Moreover, in vitro cytotoxicity and micro-array analyses were performed to better understand the mechanism of action and revealed the importance of the drug as a metal ion chelator. Together, our findings suggest that disulfiram has the potential to be repurposed as an effective antibiotic to treat superficial human skin infections.
KW - DNA arrays
KW - Staphylococcus aureus
KW - Streptococcus pyogenes
KW - antibiotics
KW - antimicrobial resistance
KW - disulfiram
KW - repurposing
KW - skin
UR - http://www.scopus.com/inward/record.url?scp=85144729523&partnerID=8YFLogxK
U2 - 10.3390/antibiotics11121752
DO - 10.3390/antibiotics11121752
M3 - Article
C2 - 36551409
SN - 2079-6382
VL - 11
JO - Antibiotics
JF - Antibiotics
IS - 12
M1 - 1752
ER -